Science ❯ Research ❯ Clinical Trials
Human Immunology OHSU Vaccine Platform Safety Assessments Adjuvant Research
Harnessing aluminum hydroxide alongside a saponin nanoparticle to sustain antigen retention for up to a month, the vaccine primes diverse B cell responses ahead of clinical trials.